New verification possibilities for ovarian malignancies
https://doi.org/10.17650/1994-4098-2011-0-4-84-86
Abstract
The fact that the diagnosis can be significantly verified using the liquid-based cytology technique and immunocytochemical assa
in analyzed 72 cases with the ascites forms of ovarian cancer. The effective panel to diagnose ovarian adenocarcinomas with ascites may be considered as follows: Ber-EP4, calretinin for the differential diagnosis of the tumor with reactive changes, as well as estrog en receptors, WT-1, CK7 for the clarification of the type of adenocarcinoma (in case of a positive reaction to Ber-EP4). Verification of the mucinous form of adenocarcinoma is now made difficult by a negative reaction to organ-specific markers.
About the Authors
A. E. Protasova
Department of Oncology, Moscow Academy of Postgraduate Education; Medical Faculty, State University; City Clinical Oncology Dispensary, Saint Petersburg
Russian Federation
Russian Federation
R. V. Orlova
Department of Oncology, Moscow Academy of Postgraduate Education; Medical Faculty, State University; City Clinical Oncology Dispensary, Saint Petersburg
G. A. Raskin
Department of Oncology, Moscow Academy of Postgraduate Education; Medical Faculty, State University; City Clinical Oncology Dispensary, Saint Petersburg
References
1. Мерабишвили В.М., Щербук Ю.А. Онкологическая служба в Санкт-Петербурге и районах города в 2009 году (заболеваемость, смертность, выживаемость). СПб., 2010.
2. Чиссов В.И., Старинский В.В.,Петрова Г.В. Злокачественные новообразования в России в 2009 году (заболеваемость и смертность). М., 2011.
3. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2007. Atlanta: American Cancer Society, 2007.
4. Wenham R.M. Ovarian cancer: a bright future. Cancer Control 2011;18:4–5.
5. Pavlidis N., Hansen H., Stahel R. ESMO Clinical Practice Guidelines: development, implementation and dissemination. Ann Oncol 2010;21:7–8.
6. De Angelis R., Francisci S., Baili P. et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009;45:909–30.
7. Chabner B.A., Lynch T.J., Longo D.L. Harrison's manual of oncology. NY: McGraw-Hill Medical, 2011; p. 517–38.
8. Ашрафян Л.А., Антонова И.Б., Ивашина С.В. и др. Ранняя диагностика рака эндометрия и яичников. Практ онкол 2009;10(2):71–5.
9. Binder R.A., Jencks J.A., Chun B., Rath C.E. "B" cell origin of malignant cells in a case of American Burkitt's lymphoma. Characterization of cells from a pleural effusion. Cancer 1975;36(1):161–8.
10. Lin O. Challenges in the interpretation of peritoneal cytologic specimens. Arch Pathol Lab Med 2009;33:739–42.
11. Kobayashi M., Ueyama Y., Nakanishi H. et al. Immunocytochemical detection using CDX2. Cancer Cytopathol 2006;108:114–8.
12. Davidson B., Risberg B., Kristensen G. et al. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Virchow Arch 1999; 435:43–9.
13. Kim J.H., Kim G.E., Choi Y.D. et al. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks. Diagn Cytopathol 2009;37:258–61.
14. Politi E., Kandaraki C., Apostolopoulou C. et al. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 2005;32:151–5.
15. Han L., Pansare V., Al-Abbadi M. et al. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology. Diagn Cytopathol 2009;37(5):321–4.
16. Lim B.J., Choi S.Y., Kang D.Y., Suh K.S. Peritoneal washing cytology of disseminated low grade endometrial stromal sarcoma: a case report. Acta Cytol 2009;53(5):587–90.
Review
For citations:
Protasova A.E., Orlova R.V., Raskin G.A. New verification possibilities for ovarian malignancies. Tumors of female reproductive system. 2011;(4):84-86. (In Russ.) https://doi.org/10.17650/1994-4098-2011-0-4-84-86
Views:
523
Email this article 